Dr. Joes holds a PhD in biochemistry from University College London, UK, and has over 20 years of experience in the pharmaceutical industry. Dr. Joes cofounded Ariella Pharmaceuticals with the goal of improving the lives of patients with neurodegenerative disorders by developing effective treatments. Her passion for helping others and her extensive research experience make her a valuable leader in the field of pharmaceuticals.

Dr. Smith holds a PhD in pharmacology from University College London, UK, and has 25 years of experience in drug discovery and development. Dr. Smith co-founded Ariella Pharmaceuticals with Dr. Joes to address the unmet medical needs of patients with neurodegenerative disorders. His expertise in pharmacology and drug development has been instrumental in the company's success in bringing innovative therapies to market.

Ms. Rose obtained a master degree in quantitative finance from the University of Manchester and started her career at Deloitte in 2005. With her previous working experience in the financial sector, Ms. Rose is responsible for financing decisions at Ariella and communicating with our key stakeholders and investors.

Mr. Brown started his career when he graduated from the master's degree in business administration at the University of Warwick. Mr. Brown was working as a human resources manager at Roche, enabling him to bring expertise in developing and executing human resource strategies to support Ariella's operations.